Preliminary safety and activity in a first-in-human phase 1 study of BLU-285, a potent, highly-selective inhibitor of KIT and PDGFRα activation loop mutants in advanced gastrointestinal stromal tumor (GIST)
暂无分享,去创建一个
Robin L. Jones | O. Mir | M. Heinrich | S. George | M. Mehren | P. Schöffski | S. Bauer | P. Cassier | B. Wolf | F. Eskens | T. Alvarez-Diez | M. E. Healy | Hongliang Shi